Inveresk Research Group, Inc. Reports Completion of Common Stock Offering, Full Exercise of Underwriters' Over-Allotment Option

Inveresk Research Group, Inc. Reports Completion of Common Stock Offering, Full
Exercise of Underwriters' Over-Allotment Option 


CARY, N.C., Nov. 25  /PRNewswire-FirstCall/ -- Inveresk Research Group, Inc. 
today announced the closing of a public offering of 11,500,000 shares of its
common stock, including 1,500,000 shares that were sold upon the exercise in
full of the underwriters' over-allotment option. The public offering price was
$20.00 per share.  The offering was comprised of 10,500,000 shares sold by
various selling stockholders, including the 1,500,000 shares sold pursuant to
the underwriters' over-allotment option, and 1,000,000 shares sold by Inveresk. 
The underwriters for the offering were Bear, Stearns & Co. Inc., Goldman, Sachs
& Co., William Blair & Company, L.L.C., SG Cowen Securities Corporation and
Jefferies & Company, Inc.

This press release shall not constitute an offer to sell or the solicitation of
an offer to buy nor shall there be any sale of these shares in any state in
which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state. Copies of the
prospectus and prospectus supplement relating to these securities may be
obtained by contacting Bear, Stearns & Co. Inc., 383 Madison Avenue, New York,
NY 10179, telephone number 212-272-2000.

Inveresk is a leading provider of drug development services to companies in the
pharmaceutical and biotechnology industries.  The company is based in Cary,
North Carolina with facilities in Edinburgh, Scotland and Montreal, Canada. 

DATASOURCE: Inveresk Research Group, Inc.



CONTACT:  Deborah Ardern-Jones, [phone], for Inveresk Research

Group, Inc.

Copyright